Pushback from drug companies on Canada’s newest drug pricing regulations has led the country's regulatory body to reconsider their implementation.…

Douglas Clark, Executive Director of the Patented Medicine Prices Review Board (PMPRB), Canada’s federal price regulator for patented medicines,…